This document is an excerpt from the EUR-Lex website
Document 22025D1852
Decision of the EEA Joint Committee No 130/2025 of 13 June 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1852]
Decision of the EEA Joint Committee No 130/2025 of 13 June 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1852]
Decision of the EEA Joint Committee No 130/2025 of 13 June 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1852]
OJ L, 2025/1852, 2.10.2025, ELI: http://data.europa.eu/eli/dec/2025/1852/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
Official Journal |
EN L series |
|
2025/1852 |
2.10.2025 |
DECISION OF THE EEA JOINT COMMITTEE No 130/2025
of 13 June 2025
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1852]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2025/457 of 10 March 2025 renewing the approval of dinotefuran as an active substance for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Decision (EU) 2025/349 of 21 February 2025 postponing the expiry date of the approval of spinosad for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Decision (EU) 2025/357 of 21 February 2025 not approving 5-chloro-2-methyl-2H-isothiazol-3-one (CIT) as an active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Commission Implementing Decision (EU) 2025/360 of 21 February 2025 postponing the expiry date of the approval of bromoacetic acid for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (4) is to be incorporated into the EEA Agreement. |
|
(5) |
Commission Implementing Decision (EU) 2025/362 of 21 February 2025 postponing the expiry date of the approval of cypermethrin for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (5) is to be incorporated into the EEA Agreement. |
|
(6) |
Commission Implementing Decision (EU) 2025/432 of 5 March 2025 postponing the expiry date of the approval of copper sulphate pentahydrate for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (6) is to be incorporated into the EEA Agreement. |
|
(7) |
Commission Implementing Decision (EU) 2025/434 of 5 March 2025 postponing the expiry date of the approval of etofenprox for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (7) is to be incorporated into the EEA Agreement. |
|
(8) |
Commission Implementing Decision (EU) 2025/444 of 5 March 2025 postponing the expiry date of the approval of benzoic acid for use in biocidal products of product-types 3 and 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (8) is to be incorporated into the EEA Agreement. |
|
(9) |
Commission Implementing Decision (EU) 2025/450 of 6 March 2025 postponing the expiry date of the approval of IPBC for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (9) is to be incorporated into the EEA Agreement. |
|
(10) |
Commission Implementing Decision (EU) 2025/459 of 10 March 2025 repealing Implementing Decision (EU) 2024/2410 postponing the expiry date of the approval of dinotefuran for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (10) is to be incorporated into the EEA Agreement. |
|
(11) |
Commission Implementing Decision (EU) 2025/461 of 10 March 2025 postponing the expiry date of the approval of aluminium phosphide releasing phosphine for use in biocidal products of product-type 20 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (11) is to be incorporated into the EEA Agreement. |
|
(12) |
Implementing Decision (EU) 2025/459 repeals Commission Implementing Decision (EU) 2024/2410 (12), which is incorporated into the EEA Agreement and which is consequently to be repealed under the EEA Agreement. |
|
(13) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II is amended as follows:
|
1. |
The following points are inserted after point 12zzzzzzzzzzzp (Commission Implementing Decision (EU) 2024/2948) of Chapter XV of Annex II to the EEA Agreement:
|
|
2. |
The text of point 12zzzzzzzzzzzf (Commission Implementing Decision (EU) 2024/2410) is deleted. |
Article 2
The texts of Implementing Regulation (EU) 2025/457 and Implementing Decisions (EU) 2025/349, (EU) 2025/357, (EU) 2025/360, (EU) 2025/362, (EU) 2025/432, (EU) 2025/434, (EU) 2025/444, (EU) 2025/450, (EU) 2025/459 and (EU) 2025/461 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 14 June 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 13 June 2025.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
(1) OJ L, 2025/457, 11.3.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/457/oj.
(2) OJ L, 2025/349, 24.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/349/oj.
(3) OJ L, 2025/357, 24.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/357/oj.
(4) OJ L, 2025/360, 25.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/360/oj.
(5) OJ L, 2025/362, 24.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/362/oj.
(6) OJ L, 2025/432, 6.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/432/oj.
(7) OJ L, 2025/434, 6.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/434/oj.
(8) OJ L, 2025/444, 7.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/444/oj.
(9) OJ L, 2025/450, 7.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/450/oj.
(10) OJ L, 2025/459, 11.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/459/oj.
(11) OJ L, 2025/461, 11.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/461/oj.
(12) OJ L, 2024/2410, 16.9.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/2410/oj.
(*1) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2025/1852/oj
ISSN 1977-0677 (electronic edition)